Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral develops devices for unmet medical needs. Sepsis occurs in 1.7M Americans/year causing 250K deaths, often caused by endotoxin. Our devices measure and remove endotoxin from the bloodstream. An FDA confirmatory trial is underway. Dialco, a Spectral sub, offers SAMI, a novel instrument for renal replacement, cleared by FDA. Dialco is seeking FDA approval for DIMI a unique home dialysis... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > "Confirmed"
View:
Post by hmmmmmmmm on Oct 17, 2022 4:40pm

"Confirmed"

Confirmed:
Adjective
setteled: rattified


Spectral stated that none of the money raised would be used for Dialco. It was an odd disclosure. Did they incorrectly think that this could somehow alter their need for disclosure of Dialco material information before raising and placing?

The problem of course is they are both under one stock- EDT.   

If at a low 40 cents- 30 million shares and options need to be printed for a raise both Spectral and Dialco
 are effected.

A suppressed price not only takes financial options away from investors, the dilution could remove 10% of the value from shares when it only needed to cost 2 or 3%
Comment by PezDalatoYou on Oct 17, 2022 5:49pm
The fact that what seems to be the easiest trial ever has not even started and has been delayed by years now. And now no committed funding for the trial either. Did Spectral have any intention at all of starting and completing the DIMI home trial? And how does that tie into tinkering with Spectral's DIMI rights with InfoMed?
Comment by mercedesman on Oct 17, 2022 10:41pm
Let's play connect the dots.  here's one ... maybe the delay in the announcement of the start of the Trial, and the as yet identified Trial partner, and the lack of allocation of equity/debenture raise dollars towards the Dialco Div., and the need to involve Infomed, has something to do with a much bigger deal ( in the works)  with said Trial Partner ? Nah.... it couldn ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities